QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mangoceuticals-q2-eps-057-up-from-135-yoy-sales-168109k-up-from-163163k-yoy

Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(...

 mangoceuticals-entered-into-mutual-rescission-and-release-agreement-with-navy-wharf-to-terminate-and-rescind-msa

-SEC Filing

 mangoceuticals-files-for-mixed-shelf-of-up-to-150m

-SEC Filing

 mangoceuticals-files-for-resale-up-to-45m-shares-of-common-stock-by-selling-shareholders

 - SEC Filing 

 mangoceuticals-entered-into-master-distribution-agreements-to-secure-exclusive-licensing-and-distribution-rights-for-diabetinol-within-us-and-canada

Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss...

 mangoceuticals-announces-advancement-in-avian-flu-prevention-with-water-based-antiviral-for-poultry-using-patented-technology-from-intramont-efficacy-demonstrated-in-phase-i-animal-studies-now-entering-phase-ii

Mangoceuticals, Inc. (NASDAQ:MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, market...

 mangoceuticals-announces-exclusive-distribution-agreement-with-propre-energie-for-dermytol-plant-based-skincare-proven-to-address-hyperpigmentation-and-acne-scars

Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variety of men's wellness pro...

 mangoceuticals-regains-full-compliance-with-nasdaq-minimum-bid-price-requirement

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

 mangorx-announces-that-it-has-initiated-a-process-to-evaluate-potential-strategic-alternatives-with-the-intent-to-unlock-and-maximize-shareholder-value-including-but-not-limited-to-potential-mergers-acquisitions-divestitures-and-business-combinations-acquisitions-of-businesses-entry-into-new-lines-of-business-business-expansions-joint-ventures-and-other-key-strategic-transactions-outside-the-ordinary-course-of-the-companys-current-business

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

Core News & Articles

MangoRx strongly refutes any and all claims made by Eli Lilly regarding the sale of compounded tirzepatide. MangoRx believes it...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION